Staff Reports
In a startling disclosure, New Mexico has claimed the dubious distinction of being the national leader in sexually transmitted infections (STIs), surpassing all other states by a significant margin. Recent data released by the Centers for Disease Control (CDC) has shed light on this disconcerting reality, revealing New Mexico's unfortunate status in the realm of STIs.
The CDC's survey assessed the prevalence of congenital syphilis, syphilis, chlamydia, and gonorrhea across the country for the year 2022. The findings are unequivocal: New Mexico has emerged as the frontrunner, or rather, the "bottom-dweller," in this undesirable category.
New Mexico a national leader in STI cases: CDC https://t.co/AhEpOqIedc via @dcexaminer
— useless eater (@bettyferal) February 26, 2024
The statistics paint a stark picture: New Mexico exhibits a staggering rate of congenital syphilis cases, standing at 355.3 per 100,000 live births—the highest incidence nationwide. Moreover, the state secures the second position in the rate of primary and secondary syphilis, with an alarming 36 cases per 100,000 individuals. Indeed, New Mexico leads the pack with unparalleled distinction—albeit in a distressing context.
But the story doesn't end there. New Mexico's prowess extends to chlamydia as well, with an infection rate of 528.6 cases per 100,000 individuals, positioning it solidly at 13th place among all 50 states. And let's not overlook gonorrhea, where the state clinches the 20th spot in reported rates, surpassing a significant number of other states. Kudos to New Mexico for its notable achievements in this regrettable arena.
The CDC's report issues a clarion call for action, emphasizing the imperative need to mobilize a comprehensive, nationwide approach in response. As STI services and related resources gradually recover from the disruptions caused by the COVID-19 pandemic and other health crises, concerted efforts are crucial to reversing this troubling trend. In essence, New Mexico is urged to prioritize concerted efforts in the public health domain, as being at the top of this particular leaderboard is far from commendable.
